Michael Dennis Piontkowski
Veterinary at Pawnee Rd, Perry, KS

License number
Colorado 4279
Issued Date
May 24, 1985
Renew Date
Nov 1, 2016
Expiration Date
Oct 31, 2018
Type
Veterinarian
Address
Address
4114 Pawnee Rd, Perry, KS 66073

Professional information

Michael Piontkowski Photo 1

Treatment Of Pigs With Pcv2 Antigent

US Patent:
2011009, Apr 21, 2011
Filed:
Dec 14, 2007
Appl. No.:
12/519135
Inventors:
Vicky Fachinger - Bad Soden, DE
Knut Elbers - Gau Algesheim, DE
Axel Lischewski - Ingelheim am Rhein, DE
Marion Kixmoeller - Muenchen, DE
Francois-Xavier Orveillon - Mainz, DE
Isabelle Freiin Von Richthofen - Charlottenlund, DK
Michael Piontkowski - Perry KS, US
Assignee:
BOEHRINGER INGELHEIM VETMEDICA, INC. - Saint Joseph MO
International Classification:
A61K 39/12, A61P 31/20
US Classification:
4242041
Abstract:
The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.


Michael Piontkowski Photo 2

Novel European Prrsv Strain

US Patent:
2012021, Aug 23, 2012
Filed:
Feb 14, 2012
Appl. No.:
13/396298
Inventors:
Kim BURGARD - Wadgassen, DE
Jeremy KROLL - Urbandale IA, US
Sarah M. LAYTON - Newton IA, US
Volker OHLINGER - Havixbeck, DE
Francois-Xavier ORVEILLON - Mainz, DE
Stefan PESCH - Munster, DE
Michael Dennis PIONTKOWSKI - Perry KS, US
Michael B. ROOF - Ames IA, US
Philip UTLEY - Slater IA, US
Eric Martin VAUGHN - Ames IA, US
Assignee:
BOEHRINGER INGELHEIM VETMEDICA, GMBH - Ingelheim am Rhein
International Classification:
A61K 39/12, C12N 7/08, C12N 15/63, A61P 31/14, C07K 14/08, C12N 15/40, C12N 7/00, A61P 37/04
US Classification:
4241861, 4352351, 435237, 4242041, 530350, 536 2372, 4353201
Abstract:
The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.